| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001054648A3 Treatment of disorders affecting vigilance related to myopathies |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/06/2002 | WO2001049324A3 Novel colloid synthetic vectors for gene therapy |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001045727A3 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/06/2002 | WO2001044207B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/06/2002 | WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/06/2002 | WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 06/06/2002 | WO2001021148B1 No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
| 06/06/2002 | WO2001012168A3 Antiviral pharmaceutical compositions containing iron chelators |
| 06/06/2002 | WO2001003684A3 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/06/2002 | WO2000065346A9 Diagnosis of human kidney diseases |
| 06/06/2002 | US20020068839 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 06/06/2002 | US20020068833 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via Ritter reaction |
| 06/06/2002 | US20020068831 Intermediate for the synthesis of amlodipine, a process for the preparation there and corresponding use |
| 06/06/2002 | US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered |
| 06/06/2002 | US20020068827 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068766 Composition and method of use |
| 06/06/2002 | US20020068765 8,9-dihydro-7H-benzocycloheptene derivatives are useful for phophylaxis and therapy of osteoporosis(have selective estrogenic activity on bones) |
| 06/06/2002 | US20020068763 N-substituted-N'-substituted urea derivative is used as a tumor necrosis factor-alpha production inhibitory agent and a therapeutical agent for autoimmune diseases |
| 06/06/2002 | US20020068762 Compositions for adhesion prevention |
| 06/06/2002 | US20020068761 Administering a therapeutically effective amount of a neutral 3:1 gallium complex of a 3- hydroxy-4-pyrone derivative to a patient infected by a prokaryote of geneus mycobacterium |
| 06/06/2002 | US20020068759 Substituted imidazole derivatives which are angiotensin II (AII) receptor antagonists useful in primary and secondary prevention of infarction |
| 06/06/2002 | US20020068758 Novel orally active iron (III) chelators |
| 06/06/2002 | US20020068757 Administering biflavanoid selected from robustaflavone, amentoflavone, agathisflavone, volkensiflavone, rhusflavanone, succedaneaflavanone, morelloflavone etc. and atleast one antiviral agent to treat viral infection |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068755 Antitumor agents. |
| 06/06/2002 | US20020068753 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | US20020068752 Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 06/06/2002 | US20020068747 Inhibitors of prenyl-protein transferase |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization |
| 06/06/2002 | US20020068743 Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/06/2002 | US20020068741 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
| 06/06/2002 | US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068736 Biphenyl compounds and their use as oestrogenic agents |
| 06/06/2002 | US20020068735 Progesterone receptor antagonist; inhibiting breast, uterine, ovarian, endometrial, or prostate cancer |
| 06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
| 06/06/2002 | US20020068732 Combination of a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist, or a salt, enantiomer or prodrug form |
| 06/06/2002 | US20020068731 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
| 06/06/2002 | US20020068728 Composition to boost libido |
| 06/06/2002 | US20020068727 Methods of prevention and treatment of ischemic damage |
| 06/06/2002 | US20020068724 Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068722 Alpha-substituted thio,-oxo trifluoromethylketones as phospholipase inhibitors |
| 06/06/2002 | US20020068721 Purine derivatives |
| 06/06/2002 | US20020068720 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068718 Chondroprotective/restorative compositions and methods of use thereof |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068709 Modulating expression of a gene involved in malignant cell growth, comprising contacting with an oligonucleotide that comprises one or more locked nucleic acid units |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
| 06/06/2002 | US20020068690 Administering a NF- kappa B inhibitor in conjunction with the administration of a chemotherapeutic agent, whereby the cytotoxic effect of said chemotherapeutic agent is increased |
| 06/06/2002 | US20020068687 Methods and compositions for inhibiting cell proliferative disorders |
| 06/06/2002 | US20020068365 Time released composition for use in the treatment of sexual disorder |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068121 Blends of isoflavones and flavones |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068100 Combination therapy for premenstrual symptoms |
| 06/06/2002 | US20020068098 Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 |
| 06/06/2002 | US20020068094 Physiologically active exract |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068079 Solution containing ethylenediaminetetraacetic acid-complex and sodium selenite for livestock feeds; provided on stick for livestock animals to lick |
| 06/06/2002 | US20020068072 Treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068068 Pathogenic bacteria (e.g. Haemophilus, E. Coli, Salmonella) having non-reverting genetic mutations which alter activity of DNA adenine methylase (Dam); vaccines |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068054 Therapeutic and cosmetic uses of heparanases |
| 06/06/2002 | US20020067880 Optical switch |
| 06/06/2002 | US20020067472 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action |
| 06/06/2002 | DE10060470A1 Thermoplastische und wasserlösliche Celluloseether-ester Thermoplastic and water-soluble cellulose ether-ester |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | DE10059415A1 Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz Use of weak opioids and mixed opioid agonist / antagonist for the treatment of urinary incontinence |
| 06/06/2002 | DE10059239A1 Kosmetische und/oder pharmazeutische Emulsionen Cosmetic and / or pharmaceutical emulsions |
| 06/06/2002 | DE10058459A1 Rhinologica Rhinologically |
| 06/06/2002 | DE10057853A1 Identifying agents that inhibit the function of specific RNA, useful e.g. for treating human or feline immune deficiency virus, comprises using a target-reporter construct prepared from a reporter ribozyme domain |
| 06/06/2002 | DE10057648A1 Verwendung von Inhibitoren von 3-Hydroxyl-3-methylglutaryl-Coenzym-A-Reduktase Use of inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase |
| 06/06/2002 | DE10057290A1 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished |
| 06/06/2002 | DE10051858A1 Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut Use of biologically degradable, substituted hydrocarbons their esters, ethers and / or amides as a nasal ointment or nasal drops for the prophylaxis of inhalation allergic reactions and for the care of the nasal mucosa |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2689915A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2625277A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436886A1 Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer |